Rong Zhou

2020

In 2020, Rong Zhou earned a total compensation of $1.5M as Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc at Amphastar Pharmaceuticals, a 28% increase compared to previous year.

Compensation breakdown

Bonus$197,269
Non-Equity Incentive Plan$112,890
Option Awards$344,011
Salary$426,409
Stock Awards$343,992
Other$32,097
Total$1,456,668

Zhou received $426.4K in salary, accounting for 29% of the total pay in 2020.

Zhou also received $197.3K in bonus, $112.9K in non-equity incentive plan, $344K in option awards, $344K in stock awards and $32.1K in other compensation.

Rankings

In 2020, Rong Zhou's compensation ranked 6,954th out of 13,090 executives tracked by ExecPay. In other words, Zhou earned more than 46.9% of executives.

ClassificationRankingPercentile
All
6,954
out of 13,090
47th
Division
Manufacturing
2,896
out of 5,620
49th
Major group
Chemicals And Allied Products
1,170
out of 2,253
48th
Industry group
Drugs
1,008
out of 1,953
48th
Industry
Pharmaceutical Preparations
752
out of 1,458
48th

Pay ratio

Rong Zhou's Pay$1,456,668
Median Employee's Pay$46,374
Pay Ratio

31

to 1

In 2020, the annual total compensation of Rong Zhou was $1,456,668.

The annual total compensation of the median employee at Amphastar Pharmaceuticals was $46,374.

The ratio of Rong Zhou's pay to the pay of median employee was therefore 31 to one.

Source: SEC filing on April 14, 2021.

Zhou's colleagues

We found five more compensation records of executives who worked with Rong Zhou at Amphastar Pharmaceuticals in 2020.

2020

Jason Shandell

Amphastar Pharmaceuticals

General Counsel

2020

Jack Zhang

Amphastar Pharmaceuticals

Chief Executive Officer

2020

Mary Luo

Amphastar Pharmaceuticals

Chief Operating Officer

2020

William Peters

Amphastar Pharmaceuticals

Chief Financial Officer

2020

Jacob Liawatidewi

Amphastar Pharmaceuticals

Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S

News

You may also like